{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:14:20Z","timestamp":1778879660072,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K12610"],"award-info":[{"award-number":["JP24K12610"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K08878"],"award-info":[{"award-number":["JP23K08878"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.gore.2025.101736","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T19:43:18Z","timestamp":1744918998000},"page":"101736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of immune radiotherapy with yttrium by targeting Frizzled homologue 10 (FZD10) in cervical cancer"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4205-3353","authenticated-orcid":false,"given":"Yuki","family":"Okuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erina","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyoun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2022","key":"10.1016\/j.gore.2025.101736_b0005","first-page":"7","article-title":"CA Cancer","volume":"72","author":"Siegel","year":"2022","journal-title":"J. Clin."},{"key":"10.1016\/j.gore.2025.101736_b0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.gore.2025.101736_b0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet."},{"key":"10.1016\/j.gore.2025.101736_b0020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMoa2112187","article-title":"Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9, Survival with cemiplimab in recurrent cervical cancer","volume":"386","author":"Tewari","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gore.2025.101736_b0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature."},{"key":"10.1016\/j.gore.2025.101736_b0030","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/S2352-3026(15)00003-4","article-title":"Rituximab plus standard of care for treatment of primary immune thrombocytopenia: A systematic review and meta-analysis","volume":"2","author":"Chugh","year":"2015","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.gore.2025.101736_b0035","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1200\/JCO.2008.17.2015","article-title":"Phase III trial of consolidation therapy with yttrium-90\u2013ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma","volume":"26","author":"Morschhauser","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2025.101736_b0040","first-page":"305","article-title":"Radioimmunotherapy in non-Hodgkin\u2019s lymphoma: Focus on 90Y-ibritumomab tiuxetan (Zevalin)","volume":"4","author":"White","year":"2004","journal-title":"J. Exp. Ther. Oncol."},{"key":"10.1016\/j.gore.2025.101736_b0045","first-page":"5859","article-title":"Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray","volume":"62","author":"Nagayama","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.gore.2025.101736_b0050","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrd.2017.91","article-title":"Opportunities for therapeutic antibodies directed at G-protein-coupled receptors","volume":"16","author":"Hutchings","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.gore.2025.101736_b0055","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1038\/sj.onc.1208780","article-title":"Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas","volume":"24","author":"Nagayama","year":"2005","journal-title":"Oncogene."},{"key":"10.1016\/j.gore.2025.101736_b0060","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2715968","article-title":"Frizzled-10 extracellular vesicles plasma concentration is associated with tumoral progression in patients with colorectal and gastric cancer","volume":"2019","author":"Scavo","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.gore.2025.101736_b0065","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/cells8080777","article-title":"FZD10 carried by exosomes sustains cancer cell proliferation","volume":"8","author":"Scavo","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.gore.2025.101736_b0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/bbrc.1999.1161","article-title":"Molecular cloning of Frizzled-10, a novel member of the frizzled gene family","volume":"262","author":"Koike","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gore.2025.101736_b0075","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1186\/s12885-018-4544-x","article-title":"A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients","volume":"18","author":"Giraudet","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gore.2025.101736_b0080","first-page":"4649","article-title":"Factors associated with radiosensitivity of cervical cancer","volume":"34","author":"Qin","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.gore.2025.101736_b0085","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154943","article-title":"Targeting mutations in cancer","volume":"132","author":"Waarts","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gore.2025.101736_b0090","first-page":"770","article-title":"Second cancers and other late side effects of cancer treatment","volume":"65","author":"Boivin","year":"1990","journal-title":"A Review, Cancer."},{"key":"10.1016\/j.gore.2025.101736_b0095","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2025.101736_b0100","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1515\/hsz-2012-0186","article-title":"Dissecting the impact of frizzled receptors in Wnt\/\u03b2-catenin signaling of human mesenchymal stem cells","volume":"393","author":"Kolben","year":"2012","journal-title":"Biol. Chem."},{"key":"10.1016\/j.gore.2025.101736_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219721","article-title":"FZD10 regulates cell proliferation and mediates Wnt1 induced neurogenesis in the developing spinal cord","volume":"15","author":"Alrefaei","year":"2020","journal-title":"PLOS ONE."},{"key":"10.1016\/j.gore.2025.101736_b0110","doi-asserted-by":"crossref","first-page":"824","DOI":"10.18632\/oncotarget.23159","article-title":"Frizzled-10 and cancer progression: Is it a new prognostic marker?","volume":"9","author":"Scavo","year":"2018","journal-title":"Oncotarget."},{"key":"10.1016\/j.gore.2025.101736_b0115","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/cas.15235","article-title":"FZD10\u2010targeted \u03b1\u2010radioimmunotherapy with 225 Ac-labeled OTSA101 achieves complete remission in a synovial sarcoma model","volume":"113","author":"Sudo","year":"2022","journal-title":"Cancer Sci."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235257892500061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235257892500061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:43:59Z","timestamp":1778877839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235257892500061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":23,"alternative-id":["S235257892500061X"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2025.101736","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of immune radiotherapy with yttrium by targeting Frizzled homologue 10 (FZD10) in cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2025.101736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101736"}}